Skip to content
20-F

Annual Report (Foreign)

China SXT Pharmaceuticals, Inc. SXTC

0001213900-23-061294

← back to feed
Filed
Jul 31, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 31, 2023 11.43M sh
Shares Diluted FY 2023 · Mar 31, 2021 719.55K sh
Eps Diluted FY 2023 · Mar 31, 2021 −$3.82